Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in adult cohort: a real-life Italian tertiary centre experience.
Ribero S, Giura MT, Viola R, Ramondetta A, Siliquini N, Cardone P, Tonella L, Quaglino P, Dapavo P, Panzone M, Ortoncelli M, Fierro MT. Ribero S, et al. Among authors: giura mt. J Eur Acad Dermatol Venereol. 2020 Aug;34(8):e380-e383. doi: 10.1111/jdv.16219. Epub 2020 May 22. J Eur Acad Dermatol Venereol. 2020. PMID: 31960496 No abstract available.
Atopic dermatitis, dupilumab and cancers: a case series.
Siliquini N, Giura MT, Viola R, Ribero S, Panzone M, Dapavo P, Fierro MT, Ortoncelli M, Quaglino P. Siliquini N, et al. Among authors: giura mt. J Eur Acad Dermatol Venereol. 2021 Oct;35(10):e651-e652. doi: 10.1111/jdv.17264. Epub 2021 Jun 11. J Eur Acad Dermatol Venereol. 2021. PMID: 33797094 No abstract available.
Lichen ruber planus arising during dupilumab treatment for atopic dermatitis.
Mastorino L, Ortoncelli M, Giura MT, Avallone G, Viola R, Quaglino P, Ribero S. Mastorino L, et al. Among authors: giura mt. Ital J Dermatol Venerol. 2022 Oct;157(5):449-450. doi: 10.23736/S2784-8671.21.07070-5. Ital J Dermatol Venerol. 2022. PMID: 36213969 Free article. No abstract available.
Risankizumab shows faster response in bio naïve than in bio-experienced psoriatic patients.
Mastorino L, Castelli F, Stroppiana E, Verrone A, Ortoncelli M, Susca S, Boskovic S, Passerini SG, Macagno N, Cariti C, Licciardello M, Solaroli C, Pertusi G, Aragone MG, Baggini G, Addese C, Leporati C, Peila R, Giura MT, Rossotto G, Pella P, Mocci L, Merlo G, Tiberio R, Graziola F, Quaglino P, Dapavo P, Ribero S. Mastorino L, et al. Among authors: giura mt. J Eur Acad Dermatol Venereol. 2022 Oct;36(10):e838-e841. doi: 10.1111/jdv.18314. Epub 2022 Jun 22. J Eur Acad Dermatol Venereol. 2022. PMID: 35686942 No abstract available.
12 results